Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Nephrology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
UKKW 2026: Sibeprenlimab Reduces Proteinuria in IgA Nephropathy Trial
March 2026
Interim results from the Phase III VISIONARY trial show that sibeprenlimab significantly reduced proteinuria and improved disease biomarkers in patients with IgA nephropathy.
Read more
12 Mar 2026
UKKW 2026: Sibeprenlimab Reduces Proteinuria in IgA Nephropathy Trial
Interim results from the Phase III VISIONARY trial show that sibeprenlimab significantly reduced proteinuria and improved disease biomarkers in patients with IgA nephropathy.
12 Mar 2026
UKKW 2026: CKD Study Questions Accuracy of Widely Used eGFR Equations
A large UK study finds commonly used eGFR equations may overestimate kidney function, potentially delaying chronic kidney disease diagnosis and treatment.
12 Mar 2026
UKKW 2026: Individualised Haemodiafiltration May Aid Clearance
A study suggests convection volume in haemodiafiltration may be tailored to patient weight and residual kidney function to optimise middle-molecule clearance.
11 Mar 2026
UKKW 2026: AKI Recovery Within 10% Predicts Long-Term Kidney Outcomes
A study of hospitalised patients with acute kidney injury shows that failing to recover creatinine within 10% of baseline at 3 months predicts worse 5-year kidney outcomes.
3 Mar 2026
Illness Severity Alters Sepsis Survival Risk in Patients with AKI
Sepsis may worsen or improve AKI survival depending on illness severity, new data suggest. Explore how risk reverses in the sickest patients. Read more.
26 Feb 2026
RPR Predicts Acute Kidney Injury After Cardiac Surgery
Elevated red cell distribution width-to-platelet ratio predicts cardiac surgery-associated acute kidney injury and improves risk stratification.
24 Feb 2026
Cognitive Impairment and Physical Decline in Patients on Haemodialysis
Study finds high rates of cognitive impairment in haemodialysis patients, with poorer physical function seen in those with established cognitive decline.
22 Feb 2026
High Incidence of Postoperative Acute Kidney Injury in Surgical ICUs
More than half of surgical ICU patients developed postoperative acute kidney injury, with sepsis, trauma, and CKD among key risk factors.
Loading posts...
1
2
3
…
24
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View